BG27746A3 - Method of obtaining of phenylpiperazine derivatives - Google Patents

Method of obtaining of phenylpiperazine derivatives

Info

Publication number
BG27746A3
BG27746A3 BG036062A BG3606277A BG27746A3 BG 27746 A3 BG27746 A3 BG 27746A3 BG 036062 A BG036062 A BG 036062A BG 3606277 A BG3606277 A BG 3606277A BG 27746 A3 BG27746 A3 BG 27746A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
phenylpiperazine derivatives
phenylpiperazine
derivatives
Prior art date
Application number
BG036062A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Verge
William Jamieson
Original Assignee
Lilly Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Limited filed Critical Lilly Industries Limited
Publication of BG27746A3 publication Critical patent/BG27746A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG036062A 1976-04-23 1977-04-20 Method of obtaining of phenylpiperazine derivatives BG27746A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
BG27746A3 true BG27746A3 (en) 1979-12-12

Family

ID=10078930

Family Applications (2)

Application Number Title Priority Date Filing Date
BG036062A BG27746A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylpiperazine derivatives
BG037191A BG28055A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylperazine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG037191A BG28055A3 (en) 1976-04-23 1977-04-20 Method of obtaining of phenylperazine derivatives

Country Status (34)

Country Link
JP (1) JPS52151183A (fr)
AR (2) AR222003A1 (fr)
AT (1) AT355579B (fr)
AU (1) AU514822B2 (fr)
BE (1) BE853899A (fr)
BG (2) BG27746A3 (fr)
CA (1) CA1087617A (fr)
CH (2) CH633009A5 (fr)
CS (1) CS196360B2 (fr)
DD (1) DD129790A5 (fr)
DE (1) DE2717415A1 (fr)
DK (1) DK176177A (fr)
ES (2) ES457988A1 (fr)
FI (1) FI63937C (fr)
FR (1) FR2348925A1 (fr)
GB (1) GB1575904A (fr)
GR (1) GR64084B (fr)
HU (1) HU176820B (fr)
IE (1) IE44730B1 (fr)
IL (1) IL51787A (fr)
LU (1) LU77170A1 (fr)
MX (1) MX4596E (fr)
NL (1) NL7704456A (fr)
NO (1) NO146710C (fr)
NZ (1) NZ183715A (fr)
OA (1) OA05643A (fr)
PH (1) PH14124A (fr)
PL (1) PL117466B1 (fr)
PT (1) PT66452B (fr)
RO (1) RO72831A (fr)
SE (1) SE7704536L (fr)
SU (2) SU664564A3 (fr)
YU (1) YU104477A (fr)
ZA (1) ZA771849B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
NZ281718A (en) * 1994-03-11 1997-08-22 Yamanouchi Pharma Co Ltd Heterocyclically-substituted (condensed) thiazoles
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
TW200804309A (en) 2006-02-28 2008-01-16 Helicon Therapeutics Inc Therapeutic piperazines
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
SE7704536L (sv) 1977-10-24
LU77170A1 (fr) 1979-01-18
ZA771849B (en) 1978-11-29
SU664564A3 (ru) 1979-05-25
GB1575904A (en) 1980-10-01
IE44730L (en) 1977-10-23
PH14124A (en) 1981-02-26
ES467948A1 (es) 1978-11-01
PT66452A (en) 1977-05-01
CS196360B2 (en) 1980-03-31
HU176820B (en) 1981-05-28
GR64084B (en) 1980-01-21
FI771287A (fr) 1977-10-24
ES457988A1 (es) 1978-07-16
DK176177A (da) 1977-10-24
NO771398L (no) 1977-10-25
AU514822B2 (en) 1981-02-26
AR222635A1 (es) 1981-06-15
BG28055A3 (en) 1980-02-25
FI63937C (fi) 1983-09-12
SU727146A3 (ru) 1980-04-05
NO146710C (no) 1982-11-24
FR2348925B1 (fr) 1980-04-11
IL51787A (en) 1980-02-29
RO72831A (fr) 1983-08-03
NZ183715A (en) 1980-04-28
AU2438677A (en) 1978-10-26
FI63937B (fi) 1983-05-31
YU104477A (en) 1983-01-21
CH633009A5 (en) 1982-11-15
PL117466B1 (en) 1981-08-31
DD129790A5 (de) 1978-02-08
OA05643A (fr) 1981-04-30
ATA285177A (de) 1979-08-15
IE44730B1 (en) 1982-03-10
NL7704456A (nl) 1977-10-25
AR222003A1 (es) 1981-04-15
AT355579B (de) 1980-03-10
JPS52151183A (en) 1977-12-15
RO72831B (ro) 1983-07-30
BE853899A (fr) 1977-10-24
DE2717415A1 (de) 1977-11-10
MX4596E (es) 1982-06-25
CH625802A5 (en) 1981-10-15
CA1087617A (fr) 1980-10-14
NO146710B (no) 1982-08-16
PT66452B (en) 1979-03-09
IL51787A0 (en) 1977-05-31
FR2348925A1 (fr) 1977-11-18
PL197550A1 (pl) 1979-05-21

Similar Documents

Publication Publication Date Title
BG27743A3 (en) Method of obtaining of aminoalkylheterocycles
BG24673A3 (en) Method of obtaining quinazone derivatives
JPS5299686A (en) Method of measuring erythrosedimentation
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
BG27734A3 (en) Method of obtaining of m- aryloxybenzaldehydes
CS192588B2 (en) Method of producing derivatives of 3-chlorocephalosporin
BG28988A4 (en) Method of obtaining of 4- halo- dihydropropyrans
BG25511A3 (en) A method of obtaining n-phosphomethylglicine derivatives
JPS5372037A (en) Method of making solventtsoluble dyestuff
BG27754A3 (en) Method of obtaining of 3- halomethylcephems
BG27746A3 (en) Method of obtaining of phenylpiperazine derivatives
PT66648A (en) Method of preparing thiazole derivatives
BG27755A3 (en) Method of obtaining of 7- alkoxy- 3- chlormethilcephems
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS52121933A (en) Method of embanking
JPS5358596A (en) Method of making polyallylpolyamines
GB1552842A (en) Method of re-treading tyres
JPS52108937A (en) Method of polybrominating bissphenoxyalkane
JPS5377090A (en) Method of etherizing
JPS52136176A (en) Method of improving 144hydroxymorphinan derivatives
BG23977A1 (en) Method of obtaining chlorethylhydrasine derivatives
GB1518280A (en) Method of preparing alpha-vinyloxazolines
JPS5358914A (en) Gradual qenching method of parts
EG14573A (en) Method of preparation for molluscidide
JPS5374148A (en) Method of falseetwisting